The Medical House PLC
Proposed Placing of New Ordinary Shares
The Medical House PLC (“the Company”), the medical equipment and devices company, announces that it is proposing to raise £710,200 (before expenses) through a placing of 1,511,064 new ordinary shares of 1p each in the Company (“New Ordinary Shares”) at a price of 47p per share (“the Placing”). The net proceeds of the Placing will provide additional working capital for the Company and will increase the free float in the Company’s issued shares.

The Placing is being undertaken by Canaccord Capital (Europe) Limited as agent for the Company pursuant to a Placing Agreement dated 11 September 2003 between Canaccord Capital (Europe) Limited and the Company and admission of the New Ordinary Shares to trading on AIM. The Placing is not underwritten.

A pension fund of which two Directors of the Company, Ian Townsend (Chief Executive) and Gerry Kemp (Operations Director), have an interest has subscribed for 287,234 New Ordinary Shares in the Placing.

Application will be made for the New Ordinary Shares to be admitted to trading on AIM. It is expected that such admission will become effective on or before 18 September 2003. The New Ordinary Shares will, when issued, rank pari passu in all respects with the existing ordinary shares of 1p each in the Company.

Commenting, Ian Townsend, Chief Executive of The Medical House PLC, said:

“This is the second placing this year as we continue to meet new institutional demand for the shares and I welcome our new shareholders in the Company. We continue to make progress with both our needle-free drug delivery systems and our orthopaedics business and we expect to report to shareholders in more detail in October with the group’s full year results.”
Notes to Editors
The Medical House PLC is quoted on AIM and specialises in the design, manufacture and distribution of medical devices and equipment. Its operations include: Eurocut, a company specialising in the design, development and manufacture of instruments for use in orthopaedic surgery; Creative Medical Design, a leading designer of medical devices and manufacturer of prototypes; and Medical House Products which undertakes the development and subsequent sale of needle-free drug delivery devices.

-ends-